No Data
Arcus a New Overweight at Wells Fargo on Potential of Casdatifan in Kidney Cancer
Zenas Started at Buy by Four Banks on Lead Drug Potential
TEVA Applications for Prolia Biosimilar Accepted by FDA, EMA
Mestag Therapeutics Enters Into A License And Collaboration Agreement With MSD To Identify Novel Targets For The Development Of Therapies Against Inflammatory Diseases; Exclusively Deploys Mestag's Proprietary RAFT Platform To Interrogate The...
Merck Posts Late-stage Trial Win for Keytruda in Head and Neck Cancer
Merck & Co Analyst Ratings